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Abstract
Background: The role of chronic renal failure (CRF) in the antimicrobial resistance of uropathogens in patients with
community-acquired acute pyelonephritis (APN) remains poorly understood.
Method: We performed a retrospective analysis of 502 adults (54 men, 448 women; mean age 61.7 ± 16.0 years,
range 18-98 years) who were treated for community-acquired APN at Kosin University Gospel Hospital (Busan,
Republic of Korea) during a ten-year period (January 2000 to December 2009). We evaluated the spectra and
antimicrobial susceptibility profiles of uropathogens in CRF and non-CRF patients with community-acquired APN
that presented as a positive urine culture.
Results: The 502 adult subjects were classified as either non-CRF APN patients (336 patients, 66.9%) or CRF APN
patients (166 patients, 33.1%) according to their estimated glomerular filtration rate. No significant differences in
the sensitivity of E. coli to a third cephalosporin, aminoglycoside (except gentamycin), or ciprofloxacin were
observed between non-CRF and CRF patients.
Conclusions: In our series of patients with community-acquired APN that initially presented as a positive urine
culture, CRF did not influence the isolation rates of different uropathogens or their patterns of susceptibility to
antimicrobials.
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Background
Acute pyelonephritis (APN), an infectious disease of the
renal parenchyma and pelvic region, is a significant and
frequent cause of morbidity, resulting in more than
100,000 hospital admissions per year in the United
States [1,2]. The most common pathogens in APN
belong to the Enterobacteriaceae family, and Escherichia
coli is the causative pathogen in more than 80% of cases
[1]. Other microbes contributing to the pathogenesis of
APN include Proteus spp, Klebsiella spp, and entero-
cocci [3]. Risk factors that predispose women to APN
include diabetes mellitus (DM), incontinence, patient
and family history of urinary tract infections (UTIs), and
certain sexual behaviors [4]. Although DM is a risk fac-
tor, it was previously reported that DM does not influ-
ence the isolation rates of different uropathogens or
their patterns of susceptibility to antimicrobials [5].
In general, CRF patients are known to be vulnerable
to infection due to weakened immunity [6]. But, few
data are available on the role of CRF as a risk factor for
the development of antimicrobial resistance of the uro-
pathogens [7]. For this reason, we have undertaken a
study to evaluate the spectrum of etiologic agents and
their profiles of antimicrobial resistance in a large series * Correspondence: danieljoseph@hanmail.net
Department of Internal Medicine, Kosin University College of Medicine,
Busan, Republic of Korea
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APN that presented as a positive urine culture.
Methods
Patients
We performed a retrospective analysis of the medical
records of Korean adults who were admitted to Kosin
University Gospel Hospital (Busan, Republic of Korea)
due to community-acquired APN between January 2000
and December 2009 and evaluated the spectra and anti-
microbial susceptibility profiles of uropathogens in both
non-CRF and CRF patients with community-acquired
APN that presented as a positive urine culture. The ana-
lysis included 502 adults aged 18 years or older (54 men,
448 women; mean age 61.7 ± 16.0 years, range 18-98
years).
Inclusion and Exclusion Criteria
Our clinical diagnosis of APN was based on the study of
Safrin et al. (1988) [8]. In addition to the clinical diagno-
sis, which was based on signs and symptoms of APN in
adult patients, patients were required to meet at least
one of the following three criteria: 1) a positive dipstick
test for leukocyte esterase; 2) a white blood cell (WBC)
count ≥ 5 cells per high-power field microscopy on
examination of centrifuged urine sediment; or 3) a WBC
count ≥ 10 cells/ μL in non-centrifuged urine.
The exclusion criteria were as follows: 1) less than 18
years of age; 2) history of chronic infection; 3) evidence
of other infection; 4) previous administration (in the
previous six months) of antibiotics; 5) urologic abnorm-
alities; 6) hospital-acquired APN (infection acquired
during hospital care which was not present or incubat-
ing at time of admission. Infections occurring more
than 48 hours after admission are usually considered
nosocomial) [9]; 7) presence of an indwelling bladder
catheter; 8) anticancer therapy or immunosuppressive
medication, such as steroids; 9) pregnancy; and 10)
negative results on urine culture.
Clinical and biochemical assessment
Type 2 diabetes was diagnosed according to the Report
of the Expert Committee on the Diagnosis and Classifi-
cation of Diabetes Mellitus [10].
As a surrogate for renal function, we estimated the
glomerular filtration rate (GFR) using a simplified form
of the Modification of Renal Disease (MDRD) equation
[11]:
Estimated GFR(eGFR) = 186×[Scr]
−1.154×[Age]
−0.203×[0.742 if patient is female]
CRF was defined as follows [12]: eGFR less than 60
mL/min/1.73 m
2 without kidney damage for more than
three months.
Baseline urine specimens were collected using a ster-
ile, midstream, clean-catch technique. Specimens were
sent to a central laboratory for urinalysis and suscept-
ibility testing, and a urine culture was performed on
each sample. Central laboratories were required to use
the methodology of the Clinical and Laboratory Stan-
dards Institute (CLSI) [13] with quality-control meth-
ods using appropriate American Type Culture
Collection organisms. Quantitative urine culture was
p e r f o r m e du s i n gad i p s l i d em e t h o d ;u r i n ew a sa l s o
streaked onto MacConkey agar. After incubation at 37°
C for 24 h, the microorganisms were identified using
standard biochemical tests. Presence of a pathogen in
the urine culture was confirmed based on a colony
count of greater than or equal to 10
5 CFU/mL. In vitro
susceptibility to antibiotics was performed using an
agar diffusion method (Kirby Bauer) employing dried
filter paper discs impregnated with specific concentra-
tions of antimicrobial agents, in accordance with the
National Committee for the Clinical Laboratory Stan-
dards [14]. Susceptibility testing results for pathogens
present upon admission were categorized as susceptible
or resistant, and susceptibility guidelines were taken
from the CLSI guidelines [13]. We also investigated
antibiotic sensitivities to ampicillin, cephalothin, cefur-
oxime, cefotaxime, cefazolin, ceftazidime, imipenem,
gentamycin, amikacin, tobramycin, ciprofloxacin, and
trimethoprim-sulfamethoxazole (TMP-SMX)
Statistical analysis
The results are presented as the mean ± SD. We used
Student’s t test to compare the means between groups.
Differences in antibiotic sensitivity and uropathogen
profiles between groups were analyzed using the X
2 test.
The results were considered significant when the P
value was less than 0.05. All statistical analyses were
performed using the Statistical Package for the Social
Sciences (SPSS), version 12.0 (SPSS Inc, Chicago, IL,
USA).
Results
The characteristics of the 502 subjects enrolled in this
s t u d ya r es h o w ni nT a b l e1 .T h em e a na g ew a s6 1 . 7( ±
16.0) years, with 89.2% of the subjects being women and
20.1% being diabetic patients.
The etiologic microorganisms of APN are shown in
Table 2. The most common cause of APN was E. coli
(58.3%, 293 cases), followed by K. pneumonia (12.7%, 64
cases), Pseudomonas (4.1%, 21 cases), and Enterococcus
(2.9%, 15 cases).
The antimicrobial sensitivity rates for E. coli are
shown in Table 3. The sensitivity rates were 100% for
imipenem, 99.2% for amikacin, 90.8% for tobramycin,
over 80% for third- and fourth-generation cephalosporin
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SMX. However, the sensitivity rates for gentamycin and
ampicillin were low (42.9% and 39.4%, respectively).
Age-gender standardized baseline demographics and
laboratory results according to eGFR are shown in
Table 1. The rates of diabetes in the non-CRF and CRF
groups were 20.8% and 21.4%, respectively (p = NS).
The mean ages were 59.0 (± 16.8) years in the non-CRF
group and 67.3 (± 12.4) years in the CRF group (p =
0.0001), and the values of HS-CRP were 7.0 (± 7.8) mg/
dL in the non-CRF group and 11.0 (± 9.4) mg/dL in the
CRF group (p = 0.002). The values for WBC (p = 0.001)
and ESR (p = 0.03) were higher in the CRF group than
in the non-CRF group.
The antimicrobial sensitivity rates (%) for E. coli accord-
ing to eGFR are shown in Table 3. The antimicrobial sen-
sitivities to ampicillin in the non-CRF group and CRF
group were 37.8% and 20.0%, respectively (p = 0.024), and
sensitivities to gentamycin in the non-CRF group and CRF
group were 71.9% and 51.9% (p = 0.016), respectively. Sig-
nificantly higher resistance of E. coli to amoxicillin and
gentamycin was noted in isolates recovered in patients
with CRF. No significant differences in the sensitivity of E.
coli were observed between non-CRF and CRF patients.
The isolation rates (%) of uropathogens in APN
patients with or without CRF are shown in Table 4. The
Table 1 Age-gender standardized baseline demographics
and laboratory results according to eGFR
eGFR ≥ 60 mL/min/
1.73 m
2,
n = 336
< 60 mL/min/
1.73 m
2,
n = 166
p-
value
Characteristics
Age, years 59.0 ± 16.8 67.3 ± 12.4 0.0001
Genders, % 0.168
Males 12.2 7.8
Females 87.8 92.2
Diabetes, % 20.8 21.4 0.906
Measurements
WBC, mm
3 9,944 ± 5,630 11,882 ± 6,233 0.001
Hb, g/dL 11.5 ± 1.9 11.1 ± 1.9 0.083
Platelet, mm
3 226,232 ±
106,223
212,380 ±
112,614
0.182
BUN, IU/L 12.4 ± 6.0 27.4 ± 14.4 0.0001
Creatinine, IU/L 0.72 ± 0.15 1.62 ± 0.64 0.0001
eGFR, mL/min/1.73 m
2 98 ± 32 39 ± 13 0.0001
Sodium, mEq/L 136 ± 5 135 ± 6 0.157
Potassium, mEq/L 3.8 ± 0.5 4.0 ± 0.7 0.003
Protein, g/dL 6.6 ± 3.6 6.3 ± 0.9 0.334
Albumin, g/dL 3.4 ± 0.6 3.2 ± 0.6 0.002
Total Bilirubin, mg/dL 1.36 ± 2.10 1.65 ± 2.14 0.172
Direct Bilirubin, mg/dL 0.74 ± 1.61 0.93 ± 1.50 0.233
AST, IU/L 47.2 ± 76.9 72.4 ± 249.3 0.216
ALT, IU/L 39.0 ± 71.6 37.2 ± 87.2 0.813
ALP, IU/L 130.5 ± 130.3 124.7 ± 133.6 0.675
r-GTP, IU/L 110.3 ± 202.9 82.9 ± 115.2 0.085
PT, second 92.5 ± 21.4 84.2 ± 22.5 0.001
PT INR 1.09 ± 0.29 1.19 ± 0.65 0.048
PTT, second 37.8 ± 13.5 39.8 ± 10.9 0.133
CRP, mg/dL 6.6 ± 7.4 8.8 ± 8.5 0.045
HS-CRP, mg/dL 7.0 ± 7.8 11.0 ± 9.4 0.002
Total cholesterol, mg/
dL
163 ± 47 154 ± 49 0.180
HDL cholesterol, mg/
dL
41 ± 16 36 ± 17 0.032
LDL Cholesterol, mg/
dL
102 ± 40 85 ± 38 0.008
Triglycerides, mg/dL 105 ± 60 131 ± 107 0.041
Chloride, mEq/L 100 ± 5 101 ± 7 0.575
total CO2, mEq/L 26.7 ± 4.8 22.7 ± 5.6 0.0001
ESR, mm/hour 30.5 ± 23.7 36.2 ± 23.0 0.030
Urine RBC (0-4+) 1.32 ± 2.22 1.36 ± 1.91 0.003
Urine protein (0-4+) 0.65 ± 0.89 0.83 ± 1.00 0.0001
Urine WBC (0-4+) 2.29 ± 2.62 2.99 ± 2.76 0.0001
Table 2 Etiologic Microorganisms of APN
Pathogen Male Female Total
E.coli 12 281 293
K.pneumoniae 85 6 6 4
Proteus 31 1 1 4
Pseudomonas 91 2 2 1
Enterococcus 21 3 1 5
G(+) 16 50 66
G(-) 42 5 2 9
Total 54 448 502
APN: Acute Pyelonephritis, G(+): Gram positive microorganism
G(-): Gram negative microorganism
Table 3 Antimicrobial Sensitivity Rate (%) for E.coli
according to eGFR
Antibiotics ≥ 60 mL/
min/
1.73 m
2
< 60 mL/
min/
1.73 m
2
p-
value
Ampicillin 37.8 20.0 0.024
Cephalothin 45.5 36.0 0.428
Cefuroxime 76.9 69.4 0.320
Cefotaxime 82.0 76.5 0.413
Cefozolin 66.7 47.1 0.162
Ceftazidime 83.2 75.5 0.259
Cepefime 83.6 80.4 0.613
Imipenem 95.5 100 0.126
Gentamycin 71.9 51.9 0.016
Amikacin 96.3 90.0 0.112
Tobramycin 87.0 82.0 0.404
Ciprofloxacin 72.7 66.0 0.389
Trimethoprime-
sulfomethoxazole
57.9 56.9 0.905
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CRF group were 54.8% and 65.7% (p = NS), and the iso-
lation rates for K. pneumoniae were 12.2% and 13.9%,
respectively (p = NS). The isolation rates of other
microorganisms did not differ between the two groups.
The antimicrobial sensitivity rates (%) for E. coli
according to DM are shown in Table 5. The antimicro-
bial sensitivities to ampicillin in the non-DM group and
DM group were 30.6% and 35.7%, respectively (p =
0.538), and sensitivities to gentamycin in the non-DM
group and DM group were 67.2% and 63.4% (p = 0.656),
respectively. The antimicrobial sensitivities to other anti-
biotics did not differ between the two groups.
Discussion and Conclusions
In this study, we attempted to determine whether there
are differences between CRF and non-CRF patients in the
bacteriologic patterns of community-acquired APN or in
the antibiotic sensitivity patterns of uropathogens. This
study showed that CRF does not seem to influence the iso-
lation rates of different uropathogens or their susceptibility
patterns to antimicrobials in patients with community-
acquired APN that presented as a positive urine culture.
In general, CRF patients are known to be vulnerable
to infection due to weakened immunity [6]. But little
information is available regarding the role of CRF as a
risk factor for the development of antimicrobial resis-
tance in uropathogens. It has been reported that DM
per se does not seem to influence the isolation rates of
different uropathogens or their susceptibility patterns to
antimicrobials [5]. In this study, the antimicrobial sus-
ceptibilities of microorganisms isolated in cases of com-
munity-acquired APN in non-DM and DM groups did
not differ. However, the role of CRF in the etiology and
antimicrobial resistance of uropathogens in patients
with community-acquired APN has not been clarified.
It is known that E. coli is isolated in approximately 90%
of APN cases [15]. Other studies have found that urinary
Klebsiella is more frequent in diabetic patients compared
to the detection rate in non-diabetic patients [16,17]. In
this study, the most common cause of APN was E. coli
(58.3%, 293 cases), followed by K. pneumoniae (12.7%, 64
cases). Due to the inclusion of diabetic patients, K. pneu-
moniae was more common than in previous reports on
APN. Among the microorganisms associated with APN, E.
coli was found in 54.8% and 65.7% of cases in the non-CRF
group and CRF group, respectively (p = NS), and K. pneu-
monia was present in 12.2% and 13.9% of cases, respec-
tively (p = NS). There were no differences between the
groups regarding the rates of other APN microorganisms.
In a previous analysis of the antibiotic sensitivity of
E. coli in APN, the sensitivities to the first- and third-
generation cephalosporins, aminoglycoside and cipro-
floxacin were greater than 90%; 47% to ampicillin; and
60% to TMP-SMX [18]. In our current study, the rate
of E. coli sensitivity was 96.9% to imipenem, 99.2% to
amikacin, 90.8% to tobramycin, greater than 80% to
third- and fourth-generation cephalosporin antibiotics,
71.7% to ciprofloxacin, and 61.4% to TMP-SMX. How-
ever, the sensitivity rates to gentamycin and ampicillin
were low (42.9% and 39.4%, respectively). Little data is
available on the role of CRF as a risk factor for the
development of antimicrobial resistance in uropatho-
gens. Antimicrobial sensitivities to ampicillin in the
non-CRF group and CRF group were 37.8% and 20.0%,
respectively (p = 0.024), and those to gentamycin in
the non-CRF group and CRF group were 71.9% and
51.9%, respectively (p = 0.016). The antimicrobial sen-
sitivities to other antibiotics did not differ between the
two groups. In North America, a cut-off point of 20%
has been suggested as the level of resistance at which
an agent should no longer be used [19]. The observed
high rates of E. coli resistance to ampicillin, cepha-
lothin, and gentamycin precludes, at least in our area,
the choice of these or similar drugs in the empirical
initial treatment of community-acquired APN in CRF
and non-CRF patients.
Table 4 Isolation rate (%) of uropathogens in APN
patients with or without CKD
Uropathogens Non-CKD CKD p-value
E. coli 54.8 65.7 NS
K. pneumoniae 12.2 13.9 NS
Proteus 2.7 3.0 NS
Pseudomonas spp 5.1 2.4 NS
Enterococcus spp 3.0 3.0 NS
Other gram positive 15.2 9.0 NS
Other gram negative 7.1 3.1 NS
Table 5 Comparison between diabetes mellitus and non-
diabetes mellitus patients with respect to antimicrobial
sensitivity rate (%) for E. coli
Antibiotics Non-DM DM p-value
Ampicilline 30.6 35.7 0.538
Cephalothin 36.7 52.9 0.227
Cefuroxime 72.2 78.4 0.456
Cefotaxime 78.2 84.2 0.420
Cefozolin 55.3 81.8 0.106
Ceftazidime 80.0 80.6 0.942
Cepefime 81.4 84.2 0.690
Imipenem 95.7 100 0.195
Gentamycin 67.2 63.4 0.656
Amikacin 92.2 100 0.081
Tobramycin 84.5 86.5 0.767
Ciprofloxacin 71.2 62.6 0.674
Trimethoprime-sulfomethoxazole 56.8 61.0 0.638
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and fluoroquinolone use in the previous six months
were independent risk factors for fluoroquinolone resis-
tance in community-onset febrile E. coli UTI [20]. In
our study, we excluded cases of previous administration
of antibiotics and hospital-acquired APN.
Recent cohort studies have suggested that CRF is also a
risk factor for non-cardiovascular morbidity [21] and mor-
tality, including those caused by infection [22,23]. Few stu-
dies have investigated the associations between CRF and
specific infectious conditions. In this study, the value of HS-
CRP was 7.0 (± 7.8) mg/dL in the non-CRF group and 11.0
(± 9.4) mg/dL in the CRF group (p = 0.002). The values of
WBC (p = 0.001) and ESR (p = 0.03) were higher in the
CRF group than they were in the non-CRF group. Based on
these results, we propose that patients with CRF had higher
values of inflammatory markers when they had APN and
that more attention is needed in this area because commu-
nity-acquired APN in CRF patients can be a serious illness.
The limitations of our study include performance on
non-CRF and CRF patients admitted to a single hospital,
although the study included a large number of patients.
Second, the CRF group was older in age than was the
non-CRF group. Finally, the results for blood culture
were not included in this study.
Based on our results, ampicillin, cephalothin, and gen-
tamycin should not be considered as an initial therapeu-
tic regimen in either CRF or non-CRF patients with
community-acquired APN. In our series of patients with
community-acquired APN presenting with a positive
urine culture test, CRF per se does not seem to influence
the isolation rates of different uropathogens or their sus-
ceptibility patterns to antimicrobials. A detailed prospec-
tive study is required to address the influences of CRF on
the spectrum and antimicrobial susceptibility of the uro-
pathogens involved in community-acquired APN.
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